Cargando…
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
SIMPLE SUMMARY: Vulvar cancer is a difficult clinical condition to treat. Although it is not one of the most frequently diagnosed cancers, its incidence is not negligible. Treatment depends on the extent of the disease and is currently based on surgery, radiotherapy and chemotherapy. The combination...
Autores principales: | Mazzotta, Marco, Pizzuti, Laura, Krasniqi, Eriseld, Di Lisa, Francesca Sofia, Cappuzzo, Federico, Landi, Lorenza, Sergi, Domenico, Pelle, Fabio, Cappelli, Sonia, Botti, Claudio, Vizza, Enrico, Tomao, Silverio, Marchetti, Luca, Sanguineti, Giuseppe, Botticelli, Andrea, Marchetti, Paolo, Magri, Valentina, Pisegna, Simona, Venuti, Aldo, Tomao, Federica, Buzzacchino, Federica, Ciliberto, Gennaro, Barba, Maddalena, Vici, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391130/ https://www.ncbi.nlm.nih.gov/pubmed/34439215 http://dx.doi.org/10.3390/cancers13164061 |
Ejemplares similares
-
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
por: Pizzuti, Laura, et al.
Publicado: (2019) -
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
por: Krasniqi, Eriseld, et al.
Publicado: (2021) -
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
por: Mazzotta, Marco, et al.
Publicado: (2019) -
COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience
por: Barba, Maddalena, et al.
Publicado: (2021) -
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
por: Marinelli, Daniele, et al.
Publicado: (2020)